Atlas Venture Associates X, LLC's Net Worth

$601 Million

Who is Atlas Venture Associates X, LLC?

Atlas Venture Associates X, LLC has an estimated net worth of $601 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals Holding Co LLC, Generation Bio Co., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., and AVROBIO, Inc..

SEC CIK

Atlas Venture Associates X, LLC's CIK is 0001742765

Past Insider Trading and Trends

2018 was Atlas Venture Associates X, LLC's most active year for acquiring shares with 6 total transactions. Atlas Venture Associates X, LLC's most active month to acquire stocks was the month of May. 2021 was Atlas Venture Associates X, LLC's most active year for disposing of shares, totalling 47 transactions. Atlas Venture Associates X, LLC's most active month to dispose stocks was the month of November. 2019 saw Atlas Venture Associates X, LLC paying a total of $15,000,003.50 for 825,056 shares, this is the most they've acquired in one year. In 2021 Atlas Venture Associates X, LLC cashed out on 35,155,530 shares for a total of $45,968,313.25, their largest year based on trade value.